I'll just clarify this bit & of course only speculative assumption.
The first would likely be a potential licensing agreement like seen before the later a straight up license - if they can show it work in mice as it does in cells it's enough to significantly increase big pharma confidence that it has stumbled across the real deal.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.015(1.16%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.31 | $1.28 | $11.03M | 8.522M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 598 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 7258 | 1 |
View Market Depth
| Last trade - 15.58pm 01/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |